What Is Tempus AI?

Introduction

Nowadays, precision medicine is emerging as a game-changer, promising to revolutionize the way we approach patient care. At the forefront of this transformation is Tempus AI, a pioneering healthcare technology company that leverages the power of artificial intelligence (AI) and vast clinical data to drive personalized, data-driven treatment decisions. With a mission to empower physicians with cutting-edge tools that learn and evolve as more data is gathered, Tempus AI is poised to reshape the future of medicine.

What is Tempus AI?

Tempus AI is a Chicago-based healthcare technology company founded in 2015 with a bold vision: to harness the vast potential of AI and data to advance precision medicine. At its core, Tempus AI is a platform that integrates one of the world’s largest libraries of clinical and molecular data, providing actionable insights to physicians and researchers.

The company’s proprietary Tempus Platform is a sophisticated system that dismantles data silos in healthcare, seamlessly integrating vast amounts of clinical and molecular data from approximately 450 unique data connections across more than 2,000 institutions. This comprehensive data repository, combined with Tempus AI’s proprietary software and dedicated data pipelines, creates a powerful network that empowers healthcare professionals to make informed, data-driven decisions.

Key Features and Capabilities

• Data and Analytics Tools: Tempus AI provides cutting-edge data and analytics tools that facilitate precision medicine by connecting laboratory test results with a patient’s clinical data. This integration enables personalized treatment plans and optimized therapy selection, ensuring that each patient receives the most appropriate care.
• Tempus Platform: The Tempus Platform is the beating heart of Tempus AI, a sophisticated system that integrates vast amounts of clinical and molecular data, dismantling data silos and creating a seamless flow of information. With proprietary software and dedicated data pipelines, the platform creates a network of healthcare institutions, enabling unprecedented collaboration and data sharing.
• Applications Beyond Oncology: While Tempus AI initially focused on oncology, the company is rapidly expanding its platform into other areas such as neuropsychology, radiology, and cardiology. This diversification is supported by strategic partnerships and data acquisition capabilities, positioning Tempus AI as a comprehensive solution for precision medicine across various medical domains.
• Financial Performance and Growth: Tempus AI’s financial performance is a testament to its potential and the growing demand for its solutions. In 2023, the company reported revenues of $531.8 million, up from $320.7 million in 2022, indicating a strong trajectory toward profitability.
• Strategic Partnerships and Acquisitions: Tempus AI has formed strategic partnerships with major pharmaceutical companies like Pfizer, GSK, and AstraZeneca, enabling collaborative efforts in drug discovery and precision oncology. Additionally, the company has acquired several startups to enhance its capabilities and solidify its position as a leader in the field.
• Innovative Product Lines: Tempus AI has launched multiple product lines, including genomics, data services, and AI applications. Notable products include the Tempus xR RNA sequencing assay and the Tempus One AI-enabled clinical assistant, which provide cutting-edge solutions for personalized patient care.

How to Use Tempus AI

Tempus AI offers a comprehensive suite of tools and platforms designed to leverage AI and multimodal data to enhance precision medicine. Here’s how healthcare providers and researchers can harness the power of Tempus AI:

1. Tempus Next: This AI-enabled care pathway intelligence platform helps clinicians identify care gaps and provides actionable insights at the point of care. It seamlessly integrates with Electronic Medical Records (EMRs) to analyze clinical notes, molecular information, and imaging data. The platform notifies care teams when a guideline or standard is not being followed, ensuring that patients receive personalized and up-to-date treatments.
2. Tempus ONE: Tempus ONE is a voice-enabled portable smart-speaker designed to assist physicians in real-time. Physicians can ask Tempus ONE questions about a patient’s condition, clinical and genomic information, and test status. The device searches the Tempus library, organizes the data into a clinical context, and provides answers to help doctors make informed decisions quickly.
3. Tempus Lens: This AI-enabled analytical platform allows users to access and analyze multimodal data. Users can migrate Tempus data records into their own environment, utilize their own computing stacks and tooling, and leverage a cohort builder to define cohorts of interest using rich molecular and clinical filters.
4. Tempus Hub: Tempus Hub is a secure platform that streamlines workflows and provides access to patient insights. It offers an intuitive order form, real-time order status tracking, comprehensive insights integrating molecular and clinical results, and the ability to securely share de-identified patient reports across multidisciplinary teams.
5. Tempus Pathology: Leveraging AI, Tempus Pathology identifies potential therapeutic options for patients earlier in their journey. It utilizes digital pathology algorithms to predict biomarkers or guide pathologist review, and integrates AI algorithms into existing pathology workflows to uncover more potential options for patients.
6. Tempus Edge: Tempus Edge is a platform that allows pathologists to access developing AI models to identify specimens with potentially actionable biomarkers. Pathologists can utilize AI models to identify patients who would benefit from additional testing and may qualify for targeted therapies, and collaborate with pharmaceutical and biotech companies to leverage the Edge platform for identifying unique biomarkers and co-developing novel AI applications.
7. Tempus Clinical Data Structuring: Tempus partners with healthcare systems and academic institutions to collect, organize, and aggregate clinical data. The company uses image recognition, optical character recognition (OCR), and natural language processing (NLP) to transform unstructured information into structured data, which can then be sold to pharmaceutical companies for research and development of new drugs.
8. Tempus AI in Research and Development: Tempus AI collaborates with biopharma organizations to leverage AI and multimodal data for drug development. The company launches pilot programs to assess the Probability of Technical Success (PTS) before and after AI and multimodal data analysis, and implements successful pilot programs as part of the governance process to benefit all development programs.

Conclusion

Tempus AI is at the forefront of integrating AI with healthcare, offering innovative solutions that enhance the ability of physicians to make informed, data-driven decisions for personalized patient care. With its mission to enable each patient to benefit from the treatment of others who came before, Tempus AI is revolutionizing the way we approach precision medicine. By harnessing the power of AI and vast clinical data, Tempus AI is paving the way for a future where personalized, effective, and efficient healthcare is within reach for all.